This blog tracks updates to the Blood Sugar 101 Web site.

Wednesday, October 18, 2017

New Fast Acting Insulin Fiasp and new GLP-1 Agonist Semaglutide Mentioned in Relevant Web Pages

Pages changed: GLP-Agonists and Insulin for Type 2 Diabetes

Brief mention made of the upcoming approval of semaglutide, the first GLP-1 agonist in pill form and of Fiasp, a new fast-acting insulin which is similar to Apidra in that it can be injected just after eating and still be effective.